UPDATE: Boston Scientific Reports FDA Approval for Latest Generation of Defib ... Benzinga Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN™ MINI and INOGEN™ MINI ICDs, ... |
